Scott Chetham PhD
Scott Chetham, PhD, is a healthcare entrepreneur and clinical development leader, and serves as Chief Executive Officer and Co-Founder of Faro Health, where he focuses on improving clinical development decision-making by applying structured data, standards, and generative artificial intelligence to the design and execution of clinical studies.
Previously, Dr. Chetham was Head of Clinical Research Operations and Data Management at Verily Life Sciences (formerly Google Life Sciences), where he led clinical strategy, operations, data management, and process development across the company’s clinical portfolio, including programs originating from Google and X.
Earlier in his career, he served as a Venture Partner at Versant Ventures and held senior leadership roles at Intersection Medical (acquired by ImpediMed) and ImpediMed, including Chief Technology Officer and Vice President of Clinical Affairs, with responsibility for clinical research strategy and execution.
Dr. Chetham began his career as a clinical scientist in global medical device and biopharmaceutical development.